Daymark Health, Inc. — Form D
Daymark Health, Inc. of Philadelphia, PA, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-26. The offering totals $5.5M, of which $5.5M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2024-08-26
- Form: D
- Accession: 0002034499-24-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.5M
- Amount sold: $5.5M
- Investors: 3
- Date of first sale: 2024-08-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-522388
Issuer
- Name: Daymark Health, Inc.
- CIK: 0002034499
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 701 E. Cathedral Rd, Suite 45 #3067, Philadelphia, PA, 19128
- Phone: 866-799-7855
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Brian Lovett | Director | San Francisco, CA |
| Robert Pahlavan | Director | Quincy, MA |
| Jonathan Rhodes | Director | San Francisco, CA |
| Paul Default | Executive Officer | San Francisco, CA |
| Alon Krashinsky | Director | San Francisco, CA |
| Alon Krashinsky | Executive Officer | San Francisco, CA |
| Ambar Bhattacharyya | Director | New York, NY |
| Paul Dufault | Executive Officer | Philadelphia, PA |
| Kelsey Maguire | Director | Philadelphia, PA |
| Roy Beveridge | Director | Chicago, IL |
| Aman Mahajan | Director | Philadelphia, PA |
| Justin Bekelman | Director | Philadelphia, PA |
| Justin Bekelman | Executive Officer | Philadelphia, PA |
| Matt Bettonville | Director | SAN FRANCISCO, CA |
Other filings by this issuer (2)
More